Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

MNOV

+ Watchlist+ Portfolio

MediciNova, Inc.

Regulated industryPhysical productsDevelopment stageTags from an AI model reading the company description.
GridBrain

GridBrain — Sign in

GridSentinel

GridSentinel — Sign in

GridAegis

GridAegis — Sign in

Key Metrics

Previous Close
$1.33
52-Week Range
$1.22 – $3.90
Market Cap
$65.07M
P/E (TTM)
—
EPS (TTM)
-0.21
Dividend Yield
0.00%
Advanced Metrics
Price/Book
1.58
PEG Ratio
—
Return on Equity
-24.80%
Return on Assets
-15.53%
Gross Margin
42.24%
Operating Margin
-1232.17%
Profit Margin
0.00%
Current Ratio
8.75
Debt/Equity
0.00
Total Debt
$100.54K
Free Cash Flow
$-6.79M
Revenue Growth
12.40%
Earnings Growth
—
Enterprise Value
$38.98M

Market Snapshot

About

MediciNova is a clinical-stage biopharmaceutical company developing therapies for diseases with unmet medical needs. The company focuses on MN-166 for neurological disorders and MN-001 for fibrotic and metabolic diseases.